Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Rao

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Cancer Cell|May 4, 2020
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary CarcinomaPavlos Msaouel, Gabriel G Malouf, Xiaoping Su, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2014
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancerMahul B Amin, Steven C Smith, Victor E Reuter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 5, 2021
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaKiril Trpkov, Ondrej Hes, Sean R Williamson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaKiril Trpkov, Sean R Williamson, Anthony J Gill, et al.
Journal of Clinical Pathology|January 30, 2021
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international surveyMahmut Akgul, Sean R Williamson, Dilek Ertoy, et al.
Nature Communications|November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidenceMelinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Virchows Archiv : an International Journal of Pathology|September 17, 2024
Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologistsSambit K Mohanty, Anandi Lobo, Shilpy Jha, et al.
Histopathology|July 30, 2024
Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literatureAnandi Lobo, Katrina Collins, Seema Kaushal, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Cancer Cell|May 4, 2020
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary CarcinomaPavlos Msaouel, Gabriel G Malouf, Xiaoping Su, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2014
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancerMahul B Amin, Steven C Smith, Victor E Reuter, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 5, 2021
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaKiril Trpkov, Ondrej Hes, Sean R Williamson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasiaKiril Trpkov, Sean R Williamson, Anthony J Gill, et al.
Journal of Clinical Pathology|January 30, 2021
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international surveyMahmut Akgul, Sean R Williamson, Dilek Ertoy, et al.
Nature Communications|November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidenceMelinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Virchows Archiv : an International Journal of Pathology|September 17, 2024
Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologistsSambit K Mohanty, Anandi Lobo, Shilpy Jha, et al.
Histopathology|July 30, 2024
Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literatureAnandi Lobo, Katrina Collins, Seema Kaushal, et al.
Pageof 12